Ruben J. Colman

Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease

Britt Christensen, Peter R. Gibson, Dejan Micić et al. · Clinical Gastroenterology and Hepatology · 2018 · 89 citations · Full text

Gastrointestinal Pharmacology, Pharmacology, Gastroenterology +5

Real‐World Infliximab Pharmacokinetic Study Informs an Electronic Health Record‐Embedded Dashboard to Guide Precision Dosing in Children with Crohn’s Disease

Ye Xiong, Tomoyuki Mizuno, Ruben J. Colman et al. · Clinical Pharmacology & Therapeutics · 2020 · 68 citations · Full text

Gastroenterology, Pharmacotherapy, Physiologically-based Pharmacokinetic Modeling +22

Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety

Britt Christensen, Ruben J. Colman, Dejan Micić et al. · Inflammatory Bowel Diseases · 2018 · 48 citations · Full text

Optimal Doses of Methotrexate Combined with Anti-TNF Therapy to Maintain Clinical Remission in Inflammatory Bowel Disease

Ruben J. Colman, David T. Rubin · Journal of Crohn s and Colitis · 2015 · 43 citations · Full text

Antibodies‐to‐infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease

Ruben J. Colman, Ye Xiong, Tomoyuki Mizuno et al. · Alimentary Pharmacology & Therapeutics · 2021 · 35 citations · Full text